The Board is appointed by the Annual General Meeting and has the overall task of managing the Company’s affairs on behalf of its shareholders. The Board continuously assesses the Group’s financial situation and evaluates the operational management.

The Board appoints the CEO and decides on significant changes in the Company’s organization and operations. The Board also ensures that the Company has satisfactory internal control over financial conditions and that information regarding the general and financial development is correctly communicated in its financial reports.

The board can be contacted at the e-mail address styrelse@vivesto.com.

 

Peter Zonabend

Name: Peter Zonabend

Title: Chairman of the Board since May 2022, and member of the Board since March 2019. Chair of the Audit Committee and member of the Remuneration Committee.

Born: 1980

Education: LL.M from Stockholm University, EMLE from Université Paul Cézanne Aix-Marseille III, Bsc in Business and Economics from Stockholm University and DU EAED from Université Paul Cézanne Aix-Marseille III.

Holdings: 720,000 shares. Manages 79,917 shares by proxy.

Previous experience: CEO of Victoria Investments Holding Ltd, 2010-2017, Law Firm Fylgia, Law Firm Björn Rosengren. Board assignments within Hövding Sverige AB, HQ AB, TCER AB, CBD Solutions AB.

Other assignments: CEO Arwidsro, board assignment within Arwidsro and member of the Board of Hoist Finance AB.

Independent in relation to Vivesto and company management, not independent of major shareholders in the company.

Download photo:
Hege Hellström

Name: Hege Hellström

Title: Member of the Board since September 2019. Member of the Audit Committee.

Born: 1965

Education: B.Sc., Medical Laboratory Scientist, 1985, Oslo Metropolitan University, Norway

Holdings: -

Previous experience: Hege worked at the biotechnology company Sobi from 2013 until 2018 and was president for EMENAR (Europe, Middle East, North Africa and Russia). Prior to that, she was globally responsible for the Cardiovascular business area within Sanofi, VP Renal Europe and Head of Regional Liaisons at Sanofi, VP Renal and Endocrine Europe at Genzyme and General Manager Benelux at Genzyme. Before Genzyme, she was 13 years at Baxter.

Other assignments: Founder and manager of Belnor BVBA, a consultancy and investment company. She is also a non-executive Board member at Camurus AB (CAMX.ST), a Swedish biotech company, and Advicenne (Euronext: ADVIC), a French pharmaceutical company.

Independent in relation to Vivesto, the company management and to major shareholders of the company.

Download photo:
Pål Ryfors

Name: Pål Ryfors

Title: Member of the Board since May 2022. Chair of the Remuneration Committee and member of the Audit Committee.

Born: 1983

Education: Bachelor in Financial Economics from Gothenburg School of Economics.

Holdings: -

Previous experience: Previously CFO for Episurf Medical, Marginalen Bank and Head of Group Controlling at Hoist Finance AB. Prior to that, he was an investment banker at Societe Generale in London, a position he assumed after holding several leading positions in the restructuring of the Swedish operations of Kaupthing Bank.

Other assignments: Chief Executive Officer of Episurf Medical AB and Chairman of the Board of Aros Kapital AB.

Independent in relation to Vivesto, the company management and to major shareholders of the company.

Download photo:
Roger Tell

Name: Roger Tell

Title: Member of the Board since May 2022, and member of the Remuneration Committee.

Born: 1965

Education: Medical degree and a doctorate in experimental oncology from the Karolinska Institute in Sweden.

Holdings: -

Previous experience: Vice President of Clinical Development at Aprea Therapeutics and International Clinical Project Director at Servier in Suresnes, France. He has an extensive experience as an oncologist as well as an advisor to biopharma companies, including Eli Lilly, Astra Zeneca and Merck Serono.

Other assignments: Chief Scientific Officer and Chief Medical Officer of Isofol Medical AB

Independent in relation to Vivesto, the company management and to major shareholders of the company.

Download photo: